Editorial
Obesity and co-morbidities in type 2 diabetes: An opportunity to bend the Health Care Cost Curve
Obesidad y comorbilidades de la diabetes tipo 2: una oportunidad para controlar la curva de costes de la asistencia sanitaria
T. Kristensen
Autor para correspondencia
Associate Professor of Health Economics, Research Unit of General Practice & Institute of Public Health, Centre of Health Economics Research, University of Southern Denmark, Odense, Denmark
K. Yderstræde
Senior Consultant, Department of Endocrinology, Odense University Hospital , Odense, Denmark
Associate Professor of Medicine, University of Southern Denmark, Odense, Denmark
Leído
1042
Vecesse ha leído el artículo
355
Total PDF
687
Total HTML
Compartir estadísticas
array:23 [ "pii" => "S0014256514000071" "issn" => "00142565" "doi" => "10.1016/j.rce.2014.01.003" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "894" "copyright" => "Elsevier España, S.L.. All rights reserved" "copyrightAnyo" => "2013" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2014;214:140-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 538 "formatos" => array:2 [ "HTML" => 290 "PDF" => 248 ] ] "itemSiguiente" => array:18 [ "pii" => "S0014256514000174" "issn" => "00142565" "doi" => "10.1016/j.rce.2014.01.011" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "903" "copyright" => "Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2014;214:143-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 643 "formatos" => array:2 [ "HTML" => 281 "PDF" => 362 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Benefits and risks in the broader incorporation of ultrasound in medical education" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "143" "paginaFinal" => "144" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Riesgos y beneficios de una mayor incorporación de la ecografía en la educación médica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Graham T. McMahon" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Graham T." "apellidos" => "McMahon" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256514000174?idApp=WRCEE" "url" => "/00142565/0000021400000003/v1_201404111205/S0014256514000174/v1_201404111205/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0014256513003822" "issn" => "00142565" "doi" => "10.1016/j.rce.2013.12.003" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "874" "copyright" => "Elsevier España, S.L." "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2014;214:137-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 713 "formatos" => array:2 [ "HTML" => 410 "PDF" => 303 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Obesidad y enfermedad coronaria. ¿Asociación compleja o paradójica?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "137" "paginaFinal" => "139" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Obesity and coronary artery disease. Complex or paradox association?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Sánchez-Recalde, J.R. González-Juanatey" "autores" => array:2 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Sánchez-Recalde" ] 1 => array:2 [ "nombre" => "J.R." "apellidos" => "González-Juanatey" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256513003822?idApp=WRCEE" "url" => "/00142565/0000021400000003/v1_201404111205/S0014256513003822/v1_201404111205/es/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Obesity and co-morbidities in type 2 diabetes: An opportunity to bend the Health Care Cost Curve" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "140" "paginaFinal" => "142" ] ] "autores" => array:2 [ 0 => array:4 [ "autoresLista" => "T. Kristensen" "autores" => array:1 [ 0 => array:4 [ "nombre" => "T." "apellidos" => "Kristensen" "email" => array:1 [ 0 => "trkristensen@health.sdu.dk" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Associate Professor of Health Economics, Research Unit of General Practice & Institute of Public Health, Centre of Health Economics Research, University of Southern Denmark, Odense, Denmark" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] 1 => array:3 [ "autoresLista" => "K. Yderstræde" "autores" => array:1 [ 0 => array:3 [ "nombre" => "K." "apellidos" => "Yderstræde" "email" => array:1 [ 0 => "knud.yderstraede@rsyd.dk" ] ] ] "afiliaciones" => array:2 [ 0 => array:2 [ "entidad" => "Senior Consultant, Department of Endocrinology, Odense University Hospital , Odense, Denmark" "identificador" => "aff0010" ] 1 => array:2 [ "entidad" => "Associate Professor of Medicine, University of Southern Denmark, Odense, Denmark" "identificador" => "aff0015" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Obesidad y comorbilidades de la diabetes tipo 2: una oportunidad para controlar la curva de costes de la asistencia sanitaria" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Obesity has long been known as a driver and predictor of the increasing global prevalence of type 2 diabetes mellitus. The World Health Organisation (WHO) has projected that more than 532 million people will developed diabetes by 2030. In Spain the evidence on the incidence of type 2 diabetes is limited due to insufficient data.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> However, it is recognized that both the incidence and the prevalence of type 2 diabetes are increasing and the age at diagnosis is decreasing. A recent national survey found that the prevalence of type 2 diabetes in Spain is 13.8% (95% CI 12.8–14.7%).<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> This prevalence can be subdivided into patients who have been diagnosed (7.8%) and those not yet diagnosed (6%). A lower prevalence of 10.3% has been reported in Catalonia and the prevalence of undiagnosed type 2 diabetes was 6.7% in this area. The national survey supported the association between diabetes and obesity. Spain's obesity prevalence rate of 28.2% ranks among the highest in the OECD countries.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Diabetes is generally a disease with a high level of comorbidity and this has to be addressed in the treatment strategy.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> The high level of comorbidity with other chronic diseases is a challenge to the single-disease and fragmented focus in the health system and represents an increasing economic burden. Comorbidity may not be adequately addressed in the current structure of health care systems.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Hospital-based systems such as DRGs are unable to capture the entire morbidity profile of patients and ignore the important impact of comorbidities. These systems focus on episodic categorization and only capture hospitalized patients and fail to address the non-hospitalized population which represents the majority of any given population. Complementary systems to hospital systems that address the entire medical experience for an individual over a period of time are needed to estimate the morbidity profile of a patient and the related economic burden. According to the literature outpatient care profiling systems such as the ACG system may assist health-care systems to better identify undiagnosed type 2 diabetic individuals, estimate cost of care and implement care coordination more effectively.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">It is a challenge to identify undiagnosed type 2 diabetic individuals for proactive treatment plans and monitoring. Often, the diagnosis of ischaemic heart disease, renal disease and peripheral vascular disease is not obtained from standard registers. The latter may, among others, be due to different focus from different specialties. Thus, a diabetic individual transferred to an orthopaedic surgical department for an amputation will not necessarily be equipped with a diagnosis of diabetes. To address the diabetes epidemic a small number of countries have established a national diabetes register based on existing administrative records.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> One advantage of this approach is that the entire population is covered by uniform inclusion criteria. Another is that the misclassification is believed to be small. Other countries conduct epidemiological surveys and/or combine data from different databases and national patient registers. Both approaches will, to some extent, serve to improve the identification and registration of type 2 diabetes patients, but the true burden of diabetes remains unknown.</p><p id="par0020" class="elsevierStylePara elsevierViewall">This issue of Rev Clin Esp features an article on the clinical and economic characteristics associated with type 2 diabetes.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> The article by Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> represents an effort to combine data from different databases in which the obesity-related expenses in diabetics are described and analyzed. Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> confirm that obesity per se is a major driving factor for the cost of co-morbidities that focus. However, the population described is biased by the fact that the obesity and diabetes groups are much older than the control group. Also, it seems surprising that only 3% of these individuals suffer from diabetic neuropathy which is far from that reported in the literature.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Epidemiological data suggest that diabetics in the same age range have a much higher rate of complications, including both obese and overweight individuals. Overall, it is a matter of concern that different populations turn out to have very variable levels of complications. A high economic burden comes from the number of amputations performed in the diabetic community and this should be added on top of those expenditures reported by Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">As Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> note in their discussion section their study of clinical and economic characteristics associated with type 2 diabetes has strength and weaknesses. It is a strength of the study that it applies recognized risk-adjustment/casemix instruments such as resource utilisations bands based on Adjusted Clinical Groups and the Charlson index to adjust for casemix. In contrast to most of the Spanish studies relating to cost of diabetes that only address healthcare cost, another advantage is that the present study includes labour productivity losses.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Application of risk screening tools is a promising method, even though some criticism has been raised towards the different comorbidity indices.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,9</span></a> Among the recognized methods are the Charlson and Adjusted Clinical Groups indices. A surprisingly low Charlson index was found by Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> and probably illustrates the difficulties in achieving accurate information from databases. Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> measure general comorbidities in three different ways: mean number of diagnoses, Charlson index and resource utilization bands. Apparently, the index condition (DM2) was included in all of the three measures of comorbidity. However, it could be argued that comorbidity measures should exclude the index condition.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> Comorbidity is morbidity in addition to an index condition rather than a general morbidity measure such as the standard Charlson and Adjusted Clinical Groups casemix measures. It could also be argued that the index condition should be excluded before the application of resource utilisation bands to describe DM2 patients’ comorbidity burden. This may be one reason why the Danish resource utilisation band measure of type 2 diabetes patients by additional morbidity burden seems to be lower (2.2 rather than 2.9). It can also be discussed whether the above-mentioned types of riskscreening tools based on retrospective information are appropriate for planning and compatible with the goal of personalized medicine.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">The Spanish literature on clinical and economic characteristics associated with type 2 diabetes is fragmented and outdated according to a recent review and the article by Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a>. In general, the rather extreme disparity has been related to differences in patient sampling, demographic factors, diabetes prevalence, variations in definitions and registration systems, access to care, and quality of healthcare systems.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> Numerous reports on the co-existence of other medical disorders in obese and/or diabetics exist and their contribution to mortality and morbidity holds a high level of prediction and stresses the cardiovascular momentum of diabetes.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Obesity is a strong predictor for developing diabetes which is also the case for cancer.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> The handling of cancer adds to the economic burden from obesity. It can be argued whether obesity is the primary factor driving the costs of type 2 diabetes patients, but it is clear that obesity and type 2 diabetes are closely related. The respective contribution to the economic burden of obesity from diabetes and cancer may be hard to disentangle, but a common denominator is cardiovascular disease leading to increased morbidity and mortality. In treating diabetes another mortality-related factor is hypoglycaemia. A recent trial<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> shows that type 2 diabetes patients’ risk of hypoglycaemia-related mortality was increased by 3.4 times that for persons without the disease. A loss of labour productivity should be added to the economic burden in work-active individuals.</p><p id="par0050" class="elsevierStylePara elsevierViewall">It should be stressed that not all obese individuals will develop diabetes. However, the data supplied by Sicrás-Mainar et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> imply that obesity is an independent factor in the expenses tied to the diabetic population. Even though the message is somewhat blurred by confounding, the data deserve credit.</p><p id="par0055" class="elsevierStylePara elsevierViewall">Even a slight weight-loss can achieve profound improvement in metabolic regulation<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a>, and an increasing number of training programmes available as applications for smartphones could potentiate the effect of training programmes.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Strong evidence shows that physical inactivity increases the risk of major non-communicable diseases such as type 2 diabetes as well as the medical and non-medical costs.<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">16,17</span></a> The literature also indicates that lifestyle changes was more effective than pharmacological intervention.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> Nevertheless, we need more evidence on the effect of lifestyle changes, anti-obesity drugs and bariatric surgery in the obese diabetic population.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Until more unambiguous evidence has been established about the best way to prevent or at least reduce type 2 diabetes, we have to focus on finding solutions for vulnerable patients and consider diabetes in the obese individual as a further complication and economic burden of society.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:17 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Costs, outcomes and challenges for diabetes care in Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Lopez-Bastida" 1 => "M. Boronat" 2 => "J.O. Moreno" 3 => "W. Schurer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1744-8603-9-17" "Revista" => array:5 [ "tituloSerie" => "Global Health" "fecha" => "2013" "volumen" => "9" "paginaInicial" => "17" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23635075" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabetes Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Soriguer" 1 => "A. Goday" 2 => "A. Bosch-Comas" 3 => "E. Bordiú" 4 => "A. Calle-Pascual" 5 => "R. Carmena" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00125-011-2336-9" "Revista" => array:6 [ "tituloSerie" => "Diabetologia" "fecha" => "2012" "volumen" => "55" "paginaInicial" => "88" "paginaFinal" => "93" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21987347" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of type 2 diabetes in the elderly" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.N. Munshi" 1 => "M. Maguchi" 2 => "A.R. Segal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11892-012-0269-4" "Revista" => array:6 [ "tituloSerie" => "Curr Diab Rep" "fecha" => "2012" "volumen" => "12" "paginaInicial" => "239" "paginaFinal" => "245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22484911" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multimorbidity: redesigning health care for people who use it" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Salisbury" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(12)60482-6" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2012" "volumen" => "380" "paginaInicial" => "7" "paginaFinal" => "9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22579042" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk-stratification methods for identifying patients for care coordination" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.R. Haas" 1 => "P.Y. Takahashi" 2 => "N.D. Shah" 3 => "R.J. Stroebel" 4 => "M.E. Bernard" 5 => "D.M. Finnie" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Manage Care" "fecha" => "2013" "volumen" => "19" "paginaInicial" => "725" "paginaFinal" => "732" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Danish National Diabetes Register: trends in incidence, prevalence and mortality" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Carstensen" 1 => "J.K. Kristensen" 2 => "P. Ottosen" 3 => "K. Borch-Johnsen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00125-008-1156-z" "Revista" => array:7 [ "tituloSerie" => "Diabetologia" "fecha" => "2008" "volumen" => "51" "paginaInicial" => "2187" "paginaFinal" => "2196" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18815769" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0213005X12001243" "estado" => "S300" "issn" => "0213005X" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and economic characteristics associated with type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Sicrás-Mainar" 1 => "R. Navarro Artieda" 2 => "J. Ibáñez Nolla" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2014" "volumen" => "314" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes and cancer: placing the association in perspective" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D.K. Andersen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MED.0b013e32835eddd3" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Endocrinol Diabetes Obes" "fecha" => "2013" "volumen" => "20" "paginaInicial" => "81" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23422245" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among Medicaid enrollees with type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "H.T. Ou" 1 => "B. Mukherjee" 2 => "S.R. Erickson" 3 => "J.D. Piette" 4 => "R.P. Bagozzi" 5 => "R. Balkrishnan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Popul Health Manage" "fecha" => "2012" "volumen" => "15" "paginaInicial" => "220" "paginaFinal" => "229" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Resources allocation and health care needs in diabetes care in Danish GP clinics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Kristensen" 1 => "O.K. Rose" 2 => "C. Sortso" 3 => "C. Ejersted" 4 => "J.L. Thomsen" 5 => "A. Halling" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.healthpol.2013.09.006" "Revista" => array:7 [ "tituloSerie" => "Health Policy" "fecha" => "2013" "volumen" => "113" "paginaInicial" => "206" "paginaFinal" => "215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24182966" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0014256510004364" "estado" => "S300" "issn" => "00142565" ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk-adjusted capitation in an era of personalized medicine: a dangerous opportunity to bend the health care cost curve" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.D. Horner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MLR.0b013e31825c3e14" "Revista" => array:6 [ "tituloSerie" => "Med Care" "fecha" => "2012" "volumen" => "50" "paginaInicial" => "633" "paginaFinal" => "634" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22683589" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Bruun" 1 => "V. Siersma" 2 => "A.D. Guassora" 3 => "P. Holstein" 4 => "O.N. de Fine" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/dme.12196" "Revista" => array:6 [ "tituloSerie" => "Diabet Med" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "964" "paginaFinal" => "972" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23617411" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased mortality of patients with diabetes reporting severe hypoglycemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.G. McCoy" 1 => "H.K. Van Houten" 2 => "J.Y. Ziegenfuss" 3 => "N.D. Shah" 4 => "R.A. Wermers" 5 => "S.A. Smith" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc11-2054" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2012" "volumen" => "35" "paginaInicial" => "1897" "paginaFinal" => "1901" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22699297" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Benefits of modest weight loss on the management of type 2 diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.C. Lau" 1 => "H. Teoh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcjd.2013.03.023" "Revista" => array:6 [ "tituloSerie" => "Can J Diabetes" "fecha" => "2013" "volumen" => "37" "paginaInicial" => "128" "paginaFinal" => "134" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24070804" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A systematic review of healthcare applications for smartphones" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.S. Mosa" 1 => "I. Yoo" 2 => "L. Sheets" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1472-6947-12-67" "Revista" => array:5 [ "tituloSerie" => "BMC Med Inform Decis Mak" "fecha" => "2012" "volumen" => "12" "paginaInicial" => "67" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22781312" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "I.M. Lee" 1 => "E.J. Shiroma" 2 => "F. Lobelo" 3 => "P. Puska" 4 => "S.N. Blair" 5 => "P.T. Katzmarzyk" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(12)61031-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2012" "volumen" => "380" "paginaInicial" => "219" "paginaFinal" => "229" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22818936" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The economic cost of physical inactivity in China" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Zhang" 1 => "J. Chaaban" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ypmed.2012.11.010" "Revista" => array:6 [ "tituloSerie" => "Prev Med" "fecha" => "2013" "volumen" => "56" "paginaInicial" => "75" "paginaFinal" => "78" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23200874" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00142565/0000021400000003/v1_201404111205/S0014256514000071/v1_201404111205/en/main.assets" "Apartado" => array:4 [ "identificador" => "1020" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editoriales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00142565/0000021400000003/v1_201404111205/S0014256514000071/v1_201404111205/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256514000071?idApp=WRCEE" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 1 | 0 | 1 |
| 2024 Octubre | 23 | 1 | 24 |
| 2024 Septiembre | 11 | 2 | 13 |
| 2024 Agosto | 25 | 1 | 26 |
| 2024 Julio | 9 | 3 | 12 |
| 2024 Junio | 13 | 2 | 15 |
| 2024 Mayo | 9 | 3 | 12 |
| 2024 Abril | 4 | 2 | 6 |
| 2024 Marzo | 6 | 3 | 9 |
| 2024 Febrero | 8 | 0 | 8 |
| 2024 Enero | 8 | 1 | 9 |
| 2023 Diciembre | 8 | 2 | 10 |
| 2023 Noviembre | 17 | 0 | 17 |
| 2023 Octubre | 8 | 2 | 10 |
| 2023 Septiembre | 11 | 2 | 13 |
| 2023 Agosto | 9 | 0 | 9 |
| 2023 Julio | 11 | 2 | 13 |
| 2023 Junio | 12 | 2 | 14 |
| 2023 Mayo | 13 | 0 | 13 |
| 2023 Abril | 8 | 0 | 8 |
| 2023 Marzo | 15 | 5 | 20 |
| 2023 Febrero | 6 | 8 | 14 |
| 2023 Enero | 9 | 0 | 9 |
| 2022 Diciembre | 8 | 2 | 10 |
| 2022 Noviembre | 13 | 4 | 17 |
| 2022 Octubre | 13 | 4 | 17 |
| 2022 Septiembre | 7 | 1 | 8 |
| 2022 Agosto | 13 | 4 | 17 |
| 2022 Julio | 14 | 3 | 17 |
| 2022 Junio | 10 | 2 | 12 |
| 2022 Mayo | 17 | 3 | 20 |
| 2022 Abril | 13 | 8 | 21 |
| 2022 Marzo | 18 | 2 | 20 |
| 2022 Febrero | 7 | 2 | 9 |
| 2022 Enero | 9 | 0 | 9 |
| 2021 Diciembre | 7 | 2 | 9 |
| 2021 Noviembre | 4 | 0 | 4 |
| 2021 Agosto | 0 | 3 | 3 |
| 2021 Julio | 0 | 1 | 1 |
| 2021 Junio | 0 | 2 | 2 |
| 2021 Marzo | 0 | 1 | 1 |
| 2021 Febrero | 0 | 4 | 4 |
| 2021 Enero | 0 | 2 | 2 |
| 2020 Diciembre | 0 | 1 | 1 |
| 2020 Noviembre | 0 | 6 | 6 |
| 2020 Octubre | 0 | 1 | 1 |
| 2020 Agosto | 0 | 4 | 4 |
| 2020 Julio | 0 | 1 | 1 |
| 2020 Marzo | 0 | 3 | 3 |
| 2020 Enero | 0 | 5 | 5 |
| 2019 Diciembre | 0 | 1 | 1 |
| 2019 Noviembre | 0 | 4 | 4 |
| 2019 Octubre | 0 | 2 | 2 |
| 2019 Septiembre | 0 | 2 | 2 |
| 2019 Agosto | 0 | 2 | 2 |
| 2019 Julio | 0 | 4 | 4 |
| 2019 Junio | 1 | 5 | 6 |
| 2019 Mayo | 0 | 15 | 15 |
| 2019 Abril | 0 | 9 | 9 |
| 2019 Marzo | 0 | 3 | 3 |
| 2019 Febrero | 0 | 2 | 2 |
| 2019 Enero | 0 | 2 | 2 |
| 2018 Diciembre | 0 | 2 | 2 |
| 2018 Noviembre | 0 | 6 | 6 |
| 2018 Octubre | 0 | 11 | 11 |
| 2018 Septiembre | 0 | 1 | 1 |
| 2018 Junio | 0 | 2 | 2 |
| 2018 Febrero | 22 | 2 | 24 |
| 2018 Enero | 16 | 3 | 19 |
| 2017 Diciembre | 13 | 2 | 15 |
| 2017 Noviembre | 12 | 5 | 17 |
| 2017 Octubre | 17 | 5 | 22 |
| 2017 Septiembre | 15 | 7 | 22 |
| 2017 Agosto | 12 | 8 | 20 |
| 2017 Julio | 12 | 5 | 17 |
| 2017 Junio | 14 | 9 | 23 |
| 2017 Mayo | 11 | 7 | 18 |
| 2017 Abril | 12 | 9 | 21 |
| 2017 Marzo | 12 | 27 | 39 |
| 2017 Febrero | 10 | 9 | 19 |
| 2017 Enero | 8 | 10 | 18 |
| 2016 Diciembre | 23 | 9 | 32 |
| 2016 Noviembre | 11 | 6 | 17 |
| 2016 Octubre | 29 | 8 | 37 |
| 2016 Septiembre | 10 | 7 | 17 |
| 2016 Agosto | 19 | 6 | 25 |
| 2016 Julio | 11 | 5 | 16 |
| 2016 Junio | 0 | 4 | 4 |
| 2016 Mayo | 0 | 4 | 4 |
| 2016 Abril | 0 | 8 | 8 |
| 2016 Marzo | 0 | 3 | 3 |
| 2016 Febrero | 0 | 2 | 2 |
Mostrar todo
